Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 2, 1998, Pages 160-166

  Archibald, Chris P ^a   Ofner, Marianna ^a   Strathdee, Steffanie A ^b   Patrick, David M ^c   Sutherland, Donald ^a   Rekart, Michael L ^c   Schechter, Martin T ^b   O'Shaughnessy, Michael V ^b  

^a LAB CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Cocaine; HIV infection; Injection drug use; Needle exchange program; Risk behaviors

Indexed keywords

COCAINE;

ACADEMIC ACHIEVEMENT; ADULT; AGE; ARTICLE; CANADA; ETHNOLOGY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SOCIOECONOMICS;

EID: 0032007086     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199802010-00010     Document Type: Article

References (42)

1. Angarano G, Pastore G, Monno L, Santantonio T, Luchena N, Schiraldi O. Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet 1985;2:1302.
2. Robertson JR, Bucknall ABV, Welsby PD, Roberts JJ, Inglis JM, Peutherer JF, Brettle RF. Epidemic of AIDS-related virus (HTLV-III/LAV) infection among intravenous drug users. Br Med J 1986; 292:527-9.
3. Kitayaporn D, Uneklabh C, Weniger BG, Lohsomboom P, Kaewkungwal J, Morgan WM, Uneklash T. Incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 1994;8:1443-50.
4. O'Hare P, Newcombe R, Matthews A, Buning EC, Drucker E (eds). The reduction of drug-related harm. London: Routledge, 1992.
5. Lurie P, Reingold A, Bowser B, et al. The public health impact of needle exchange programs in the United States and abroad: summary, conclusions and recommendations. San Francisco: School of Public Health, University of California, Berkeley, and Institute for Health Policy Studies, University of California, San Francisco, October 1993.
6. Guydish J, Bucardo J, Young M, Woods W, Grinstead O, Clark W. Evaluating needle exchange: are there negative effects? AIDS 1993;7:871-6.
7. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994;271:115-20.
8. Hartgers C, van Ameijden EJC, van den Hoek JAR, Coutinho RA. Needle sharing and participation in the Amsterdam syringe exchange program among HIV-seronegative injecting drug users. Public Health Reports 1992;107:675-81.
9. van Ameijden EJC, van den Hoek JAR, Coutinho RA. Injecting risk behaviour among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994;84:275-81.
10. Klee H, Morris J. The role of needle exchanges in modifying sharing behaviour: cross-study comparisons, 1989-1993. Addiction 1995;90:1635-45.
11. Donoghoe MC, Dolan KA, Stimson GV. Changes in injectors' HIV risk behaviour and syringe supply in UK, 1987-90. Final program and abstracts of the Seventh International Conference on AIDS. Florence, Italy, 1991.
12. Kaplan EH, Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr 1994;7:182-9.
13. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, Jose B, Friedman SR. HIV incidence among injecting drug users in the New York City syringe-exchange programmes. Lancet 1996;348: 987-91.
14. Van Ameijden EJC, van den Hoek JAR, van Haastrecht HJA, Coutinho RA. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol 1992;136:236-43.
15. Bruneau J, Lamothe F, Franco E, Lachance N, Desy M, Soto J, Vincelette J. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol 1997;146:994-1002.
16. Neaigus A, Friedman SR, Jose B, Goldstein MF, Curtis R, Ildefonso G, Des Jarlais DC. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:499-509.
17. Stimson GV. Syringe-exchange programmes for injecting drug users. AIDS 1989;3:253-60.
18. Hartgers C, Buning EC, van Santen GW, Verster AD, Coutinho RA. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. AIDS 1989;3:571-6.
19. Donoghoe MC, Stimson GV, Dolan K, Alldritt L. Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland. AIDS 1989;3:267-72.
20. Harris N, McGough J, Shapiro E, Fields J, Weiss N. The impact of a syringe-exchange program on drug-injection behaviour associated with HIV in Seattle, Washington, USA [abstract PO- C24-3178]. Final program and abstracts of the IX International Conference on AIDS. Berlin, 1993.
21. Hagan H, Des Jarlais DC, Purchase D, Reid TR, Friedman SR. Lower HIV seroprevalence, declining HBV and safer injection in relation to the Tacoma syringe exchange [abstract WC 3291]. Final program and abstracts of the VII International Conference on AIDS. Florence, 1991.
22. Frischer M, Elliott L. Discriminating needle exchange attenders from non-attenders. Addiction 1993;88:681-7.
23. Patrick DM, Strathdee SA, Archibald CP, et al. Outbreak Vancouver: why is HIV spreading among injection drug users (IDU) in a city with longstanding needle exchange and outreach services [abstract]? Third Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 1996.
24. Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS 1997;8:427-35.
25. Harvey E, Strathdee SA, Patrick DM, Ofner M, Archibald CP, Eades G, O'Shaughnessy MV. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. AIDS Care 1998, in press.
26. Mirowsky J, Ross CE. Age and depression. J Health Soc Behav 1992;33:187-205.
27. Vlahov D, Junge B, Beilenson P, Brookmeyer RS, Cohn S, Armenian H. Evaluation of the Baltimore needle exchange program: preliminary results. Final program and abstracts of the XI International Conference on AIDS [abstract Mo.D.361]. Vancouver, 1996.
28. Hahn JA, Vranizan KM, Moss AR. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-90. J Acquir Immune Defic Syndr Human Retrovirol 1997;15:157-64.
29. Bruneau J, Lamothe F, Lachance N, Soto J, Vincelette J. HIV prevalence and incidence in a cohort of IDUs in Montreal, according to their needle exchange attendance. Final program and abstracts of the Tenth International Conference on AIDS [abstract PD 0496]. Yokohama, Japan, 1994.
30. Kim MY, Marmor M, Dubin N, Wolfe H. HIV risk-related sexual behaviours among heterosexuals in New York City: associations with race, sex, and intravenous drug use. AIDS 1993;7:409-14.
31. Hudgins R, McCusker J, Stoddard A. Cocaine use and risky injection and sexual behaviours. Drug Alcohol Depend 1995;37:7-14.
32. Joe GW, Simpson DD. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend 1995;37:23-8.
33. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989;261:561-5.
34. Anthony JC, Vlahov D, Nelson KE, Cohn S, Astemborski J, Solomon L. New evidence on intravenous cocaine use and risk of infection with human immunodeficiency virus type 1. Am J Epidemiol 1991;134:1175-89.
35. Strathdee SA, Patrick DM, Archibald CP, et al. Social determinants predict needle sharing behaviour among injection drug users in Vancouver, Canada. Addiction 1997;92:1339-48.
36. Normand J, Vlahov D, Moses LE. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Research Council, Institute of Medicine, National Academy Press, 1995.
37. Celentano DD, Vlahov D, Cohn S, Anthony JC, Solomon L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health 1991;81:1291-5.
38. Saxon AJ, Calsyn DA, Jackson TR. Longitudinal changes in injection behaviours in a cohort of injection drug users. Addiction 1994;89:191-202.
39. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med 1994;38:67-78.
40. Samuels JF, Vlahov D, Anthony JC, Chaisson RE. Measurement of HIV risk behaviours among intravenous drug users. Br J Addiction 1992;87:417-28.
41. Watters JK, Needle R, Brown BS, Weatherby N, Booth R, Williams M. The self-reporting of cocaine use. JAMA 1992;268: 2374-5.
42. Strathdee SA, Patrick DM, Currie S, et al. Needle exchange is not enough: lessons from the Vancouver Injection Drug Use Study. AIDS 1997;11:F59-F65.